“The Association Of Dietary Lutein Plus Zeaxanthin And B Vitamins With Cataracts In The Age-Related Eye Disease Study: Areds Report No. 37”. Opthalmology 122. Opthalmology: 1471-1479. http://www.ncbi.nlm.nih.gov/pubmed/25972257.
. 2015. . 2015.
“Ciliary Neurotrophic Factor For Macular Telangiectasia Type 2: Results From A Phase 1 Safety Trial”. Am J Ophthalmol 159. Am J Ophthalmol: 659-666.e1. http://www.ncbi.nlm.nih.gov/pubmed/25528956.
. 2015. “Genetic Testing In Persons With Age-Related Macular Degeneration And The Use Of The Areds Supplements: To Test Or Not To Test?”. Ophthalmology 122. Ophthalmology: 212-215. http://www.ncbi.nlm.nih.gov/pubmed/25456150.
. 2015. “Intravitreal Sirolimus For The Treatment Of Geographic Atrophy: Results Of A Phase I/ii Clinical Trial”. Invest Ophthalmol Vis Sci 56. Invest Ophthalmol Vis Sci: 330-338. http://www.ncbi.nlm.nih.gov/pubmed/25525171.
. 2015. . 2014.
. 2014.
“Randomized Trial Of The Foreseehome Monitoring Device For Early Detection Of Neovascular Age-Related Macular Degeneration. The Home Monitoring Of The Eye (Home) Study Design - Home Study Report Number 1”. Contemporary Clinical Trials 37. Contemporary Clinical Trials: 294-300. http://www.ncbi.nlm.nih.gov/pubmed/24530651.
. 2014. “Ten-Year Follow-Up Of Age-Related Macular Degeneration In The Age-Related Eye Disease Study: Areds Report No. 36”. Jama Ophthalmol 132. Jama Ophthalmol: 272-277. http://www.ncbi.nlm.nih.gov/pubmed/24385141.
. 2014. “Visual Acuity After Cataract Surgery In Patients With Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 5”. Ophthalmology 121. Ophthalmology: 1229-1236. http://www.ncbi.nlm.nih.gov/pubmed/24613825.
. 2014. “Evaluation Of Optimized Digital Fundus Reflex Photographs For Lens Opacities In The Age-Related Eye Disease Study 2: Areds2 Report 7”. Invest Ophthalmol Vis Sci 54. Invest Ophthalmol Vis Sci: 5989-5994. http://www.ncbi.nlm.nih.gov/pubmed/23887802.
. 2013. “Long-Term Effects Of Vitamins C And E, Β-Carotene, And Zinc On Age-Related Macular Degeneration: Areds Report No. 35”. Opthalmology 120. Opthalmology: 1604-1611e.4. http://www.ncbi.nlm.nih.gov/pubmed/23582353.
. 2013. “Medical Characteristics Of Patients With Macular Telangiectasia Type 2 (Mactel Type 2) Mactel Project Report No. 3”. Ophthalmic Epidemiol 20. Ophthalmic Epidemiol: 109-113. http://www.ncbi.nlm.nih.gov/pubmed/23510315.
. 2013. “Methods And Reproducibility Of Grading Optimized Digital Color Fundus Photographs In The Age-Related Eye Disease Study 2 (Areds2 Report Number 2)”. Invest Ophthalmol Vis Sci 54. Invest Ophthalmol Vis Sci: 4548-4554. http://www.ncbi.nlm.nih.gov/pubmed/23620429.
. 2013. “Spectral-Domain Optical Coherence Tomography Characteristics Of Intermediate Age-Related Macular Degeneration”. Opthalmology 120. Opthalmology: 140-150. http://www.ncbi.nlm.nih.gov/pubmed/22968145.
. 2013. “Ten-Year Incidence Rates Of Age-Related Cataract In The Age-Related Eye Disease Study (Areds). Areds Report No. 33”. Ophthalmic Epidemiology 20. Ophthalmic Epidemiology: 71-81. http://www.ncbi.nlm.nih.gov/pubmed/23510310.
. 2013. “Treatment Of Geographic Atrophy With Subconjunctival Sirolimus: Results Of A Phase I/ii Clinical Trial”. Invest Ophthalmol Vis Sci 54. Invest Ophthalmol Vis Sci: 2941-2950. http://www.ncbi.nlm.nih.gov/pubmed/23548622.
. 2013. “The Age-Related Eye Disease Study 2 (Areds2): Study Design And Baseline Characteristics (Areds2 Report No. 1)”. Ophthalmology 119. Ophthalmology: 2282-2289. http://www.ncbi.nlm.nih.gov/pubmed/22840421.
. 2012. “The Development Of Amd In Participants With No Or Small Drusen In The Age-Related Eye Disease Study (Areds)”. In Association For Research In Vision And Ophthalmology - Arvo. Association For Research In Vision And Ophthalmology - Arvo. Ft. Lauderdale, FL. http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=f88639c1-7b91-4362-b0a1-c52c8ea07bc0&cKey=ea798c55-e42e-46fe-8103-3b1cc4288bd8&mKey={F0FCE029-9BF8-4E7C-B48E-9FF7711D4A0E}.
. 2012. “Effective Monitoring Strategies In A Long-Term Clinical Trial With Varying Levels Of Clinic Staff”. In Society For Clinical Trials. Society For Clinical Trials. Miami, FL. http://www.sctweb.org/public/meetings/2012/home.cfm.
. 2012. “"en Face" Oct Imaging Of The Is/os Junction Line In Type 2 Idiopathic Macular Telangiectasia”. Invest Ophthalmol Vis Sci 53. Invest Ophthalmol Vis Sci: 6145-6152. http://www.ncbi.nlm.nih.gov/pubmed/22899757.
. 2012. “The Is/os Junction Layer In The Natural History Of Type 2 Idiopathic Macular Telangiectasia”. Invest Ophthalmol Vis Sci 53. Invest Ophthalmol Vis Sci: 7889-7895. http://www.ncbi.nlm.nih.gov/pubmed/23092925.
. 2012. “Spatial Correlation Between Hyperpigmentary Changes On Color Fundus Photography And Hyperreflective Foci On Sdoct In Intermediate Amd”. Invest Ophthalmol Vis Sci 53. Invest Ophthalmol Vis Sci: 4626-4633. http://www.ncbi.nlm.nih.gov/pubmed/22589439.
. 2012. “Tracking Of Regulatory Documents In A Large Clinical Trial, The Age-Related Eye Disease Study 2”. In Society For Clinical Trials. Society For Clinical Trials. Miami, FL. http://www.sctweb.org/public/meetings/2012/home.cfm.
. 2012. “Longitudinal Analysis Of Retinal Hemangioblastomatosis And Visual Function In Ocular Von Hippel Lindau Disease”. In Association For Research In Vision And Ophthalmology - Arvo. Association For Research In Vision And Ophthalmology - Arvo. Ft. Lauderdale, FL. http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=35158719-dd7e-45ba-99ce-b6985470c55f&cKey=964c5cb7-7847-46a9-a518-dc2b826dc06d&mKey={6F224A2D-AF6A-4533-8BBB-6A8D7B26EDB3}.
. 2011.